tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

FibroBiologics Raises Funds Through Strategic Equity Sales to GEM

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from FibroBiologics, Inc. (FBLG).

FibroBiologics, Inc. sold 100,000 shares to GEM at $4.51 each, after a 10% discount, totaling $451,000 in proceeds. This followed a previous transaction where 3 million shares facilitated a draw down, with GEM accepting 840,000 of these at $4.09 per share, providing FibroBiologics with $3.44 million in proceeds. The unutilized 1.5 million shares from the draw down notice will be returned and cancelled, with the Company having received a total of $3.89 million from its sales under the share purchase agreement with GEM.

For an in-depth examination of FBLG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1